These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2005707

  • 1. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.
    Thüroff JW, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schäfer W.
    J Urol; 1991 Apr; 145(4):813-6; discussion 816-7. PubMed ID: 2005707
    [Abstract] [Full Text] [Related]

  • 2. Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia.
    Gajewski JB, Awad SA.
    J Urol; 1986 May; 135(5):966-8. PubMed ID: 3959249
    [Abstract] [Full Text] [Related]

  • 3. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.
    Holmes DM, Montz FJ, Stanton SL.
    Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633
    [Abstract] [Full Text] [Related]

  • 4. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH, Hay DM, Imrie AE, Watson A, Goldstein M.
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [Abstract] [Full Text] [Related]

  • 5. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M, Madersbacher H, Palmtag H, Stöhrer M, Bödeker RH, P195 Study Group.
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [Abstract] [Full Text] [Related]

  • 6. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Brühl B, Höfner K, Jonas U.
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [Abstract] [Full Text] [Related]

  • 7. Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline.
    Coombes GM, Millard RJ.
    Med J Aust; 1996 Nov 04; 165(9):473-6. PubMed ID: 8937366
    [Abstract] [Full Text] [Related]

  • 8. Anticholinergic medication for the unstable bladder: prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate.
    Clarke B.
    Int Urogynecol J Pelvic Floor Dysfunct; 1996 Nov 04; 7(4):191-5. PubMed ID: 10895803
    [Abstract] [Full Text] [Related]

  • 9. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS, Burgio KL, Locher JL, Umlauf MG, Lloyd LK, Roth DL.
    J Am Geriatr Soc; 2002 May 04; 50(5):808-16. PubMed ID: 12028165
    [Abstract] [Full Text] [Related]

  • 10. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.
    Madersbacher H, Halaska M, Voigt R, Alloussi S, Höfner K.
    BJU Int; 1999 Oct 04; 84(6):646-51. PubMed ID: 10510109
    [Abstract] [Full Text] [Related]

  • 11. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
    Yarker YE, Goa KL, Fitton A.
    Drugs Aging; 1995 Mar 04; 6(3):243-62. PubMed ID: 7620236
    [Abstract] [Full Text] [Related]

  • 12. Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
    Madersbacher H, Stöhrer M, Richter R, Burgdörfer H, Hachen HJ, Mürtz G.
    Br J Urol; 1995 Apr 04; 75(4):452-6. PubMed ID: 7788255
    [Abstract] [Full Text] [Related]

  • 13. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Moisey CU, Stephenson TP, Brendler CB.
    Br J Urol; 1980 Dec 04; 52(6):472-5. PubMed ID: 7006730
    [Abstract] [Full Text] [Related]

  • 14. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
    George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S.
    ScientificWorldJournal; 2007 Oct 22; 7():1683-90. PubMed ID: 17982563
    [Abstract] [Full Text] [Related]

  • 15. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M, Mürtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ, Propiverine Investigator Group.
    Eur Urol; 2007 Jan 22; 51(1):235-42. PubMed ID: 16698176
    [Abstract] [Full Text] [Related]

  • 16. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ, Cardozo LD, Versi E, Cooper D.
    Br J Obstet Gynaecol; 1990 Jun 22; 97(6):521-6. PubMed ID: 2198921
    [Abstract] [Full Text] [Related]

  • 17. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA, Quiroga Avila RG, Lorenzo Monterrubio JL, Moreno Aranda J.
    Ginecol Obstet Mex; 2000 Apr 22; 68():174-81. PubMed ID: 10824450
    [Abstract] [Full Text] [Related]

  • 18. Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate.
    Iselin CE, Schmidlin F, Borst F, Rohner S, Graber P.
    Br J Urol; 1997 Jun 22; 79(6):915-9. PubMed ID: 9202559
    [Abstract] [Full Text] [Related]

  • 19. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB.
    J Urol; 1994 Apr 22; 151(4):944-5. PubMed ID: 8126833
    [Abstract] [Full Text] [Related]

  • 20. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment.
    Riva D, Casolati E.
    Clin Exp Obstet Gynecol; 1984 Apr 22; 11(1-2):37-42. PubMed ID: 6370504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.